December 1, 2015
AHF marks World AIDS Day with HIV testing & awareness events in 32 countries
AHF Marks World AIDS Day with HIV Testing & Awareness Events in 32 Countries; Celebrates Milestone: 500,000 Lives in Care
pharmaceutical daily
Pharmaceuticals, Biotechnology and Life Sciences
December 1, 2015
Celyad advances first NKG2D CAR T-Cell Phase I study
Celyad advances first NKG2D CAR T-Cell Phase I study
December 1, 2015
French Biophytis appoints new Director of Research
Biophytis has appointed Pierre J. Dilda, PhD, as Director of
Research.
December 1, 2015
Frances Neovacs engaging in immuno-oncology
Neovacs, a France-based specialist in active immunotherapies for the treatment of autoimmune diseases, has decided to engage in the field of immuno-oncology after a recommendations by its Scientific Adivsory Board
December 1, 2015
Tuberculosis funding gap threatens elimination goals
Funding for tuberculosis research fell $1.3 billion short of global targets last year, threatening worldwide goals to eliminate the disease between 2030 and 2035, researchers said on Monday.
December 1, 2015
Velneva’s Clostridium difficile vaccine Candidate meets Phase II trial target
Velneva’s Clostridium difficile vaccine Candidate meets Phase II trial target
November 30, 2015
DNA repair factor linked to breast cancer may also play a role in Alzheimer’s disease
Low levels of breast cancer factor 1 (BRCA1) protein in the brain may contribute to dementia, according to results of a National Institutes of Health (NIH)-funded study, published in Nature Communications.
November 30, 2015
Janssen asks for its Chron’s disease drug Stelara U.S. and EU approval
Janssen Biotech, Inc. and Janssen-Cilag International NV (Janssen) are seeking approval from the U.S. and European authorities for Chron’s disease drug Stelara.
November 30, 2015
European Commission approves Horizon’s Ravicti for treating Urea Cycle Disorders
Horizon Pharma and its affiliate, Horizon Therapeutics, has gotten the European Commission’s (EC’s) approval for Ravicti – glycerol phenylbutyrate – Oral Liquid for use as an adjunctive therapy for chronic management patients with six subtypes of Urea Cycle Disorders (UCDs).
November 30, 2015
In rural South Africa, AIDS treatment gains ground – but so do infections
When HIV-positive patients first came to seek treatment at the rural Uthungulu district health clinic in South Africa’s eastern KwaZulu-Natal province in 1998, their records were kept in brown folders, the colour designated for the disease.